20.58
Kestra Medical Technologies Ltd stock is traded at $20.58, with a volume of 377.57K.
It is down -0.58% in the last 24 hours and down -18.50% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$20.70
Open:
$20.75
24h Volume:
377.57K
Relative Volume:
1.09
Market Cap:
$1.20B
Revenue:
$83.72M
Net Income/Loss:
$-143.89M
P/E Ratio:
-7.3166
EPS:
-2.8128
Net Cash Flow:
$-120.48M
1W Performance:
+5.11%
1M Performance:
-18.50%
6M Performance:
-14.68%
1Y Performance:
-18.37%
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KMTS
Kestra Medical Technologies Ltd
|
20.58 | 1.21B | 83.72M | -143.89M | -120.48M | -2.8128 |
|
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | BTIG Research | Buy |
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
Kestra Medical Technologies' (KMTS) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year” - GlobeNewswire
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Q3 2026 earnings call transcript - MSN
Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $304,050.00 in Stock - Defense World
A Look At Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness - Sahm
Kestra Medical prices upsized $138M offering - MSN
Insider Sell: Brian Webster Sells 15,000 Shares of Kestra Medica - GuruFocus
Webster, CEO of Kestra Medical, sells $304k in KMTS shares - Investing.com India
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 15,000 Shares of Stock - MarketBeat
Analyst Downgrade: Whats the fair value of LUNR stockMarket Sentiment Review & Detailed Earnings Play Strategies - baoquankhu1.vn
Kestra Medical Technologies Insider Sold Shares Worth $304,124, According to a Recent SEC Filing - marketscreener.com
Kestra Medical (KMTS) director sells 15,000 shares under 10b5-1 plan - Stock Titan
Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE) - The Globe and Mail
KMTS SEC FilingsKESTRA MED TECHNOLOGIES LTD 10-K, 10-Q, 8-K Forms - Stock Titan
Wells Fargo Keeps Their Buy Rating on Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE) - The Globe and Mail
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% Following Weak Earnings - Defense World
Kestra Medical Technologies (KMTS) Revenue Growth Versus Ongoing EPS Losses Tests Bullish Narratives - simplywall.st
Kestra Medical Technologies Q3 Earnings Call Highlights - Yahoo Finance
Kestra Medical Technologies, Ltd. 2026 Q1 10-Q Report: Financial Statements, Risk Factors, and Forward-Looking Statements - Minichart
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 8.7% After Earnings Miss - MarketBeat
Piper Sandler reiterates Kestra Medical stock rating on strong Q3 By Investing.com - Investing.com South Africa
Kestra Medical Technologies' (KMTS) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat
KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary - Yahoo Finance
Kestra Medical Technologies’ revenue up 63% to USD 24.6M in Q3 FY26 - Medical Buyer
Kestra Medical Technologies Q3 2026 Earnings Call Transcript - MarketBeat
Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ... By GuruFocus - Investing.com Canada
Trend Report: Does Kestra Medical Technologies Ltd have declining or rising EPS2026 Top Gainers & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Earnings call transcript: Kestra Medical Technologies reports Q3 2026 earnings miss but sees stock rise - Investing.com Australia
Kestra raises 2026 revenue guidance to $93M while advancing market expansion and margin gains - MSN
KMTS: Q3 revenue up 63% year-over-year, gross margin expands, and 2026 guidance raised to $93M - TradingView
Kestra Medical (KMTS) Q3 2026 Earnings Transcript - The Globe and Mail
Insider sells 45,000 KMTS shares across three trades (KMTS) - Stock Titan
Kestra Medical Technologies reports $24.6M Q3 revenue, $(0.61) EPS - TradingView
Kestra Medical (Nasdaq: KMTS) boosts revenue as losses deepen on growth spend - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Kestra Medical Technologies, Ltd. Raises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Kestra Medical Technologies : Company Overview - marketscreener.com
Kestra Medical Fiscal Q3 Loss Narrows, Revenue Rises; Raises Fiscal 2026 Revenue Outlook - marketscreener.com
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results - The Manila Times
Kestra Medical Technologies reports Q3 revenue $24.6M, gross margin 52.6% - TradingView
Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q3 Revenue $24.6M, vs. FactSet Est of $22.9M - marketscreener.com
Kestra Medical Technologies, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026 - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Trading Up 7%Should You Buy? - MarketBeat
Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You N - GuruFocus
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies Ltd expected to post a loss of 60 cents a shareEarnings Preview - TradingView
Kestra Medical Technologies Ltd (KMTS) Shares Gap Down to $18.12 - GuruFocus
Kestra Medical (KMTS) director receives 8,300 restricted stock units as award - Stock Titan
Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 9%Time to Sell? - MarketBeat
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):